Accordingly, an increase in CD8+ T-cell response and reduction in tumor growth in the murine lung cancer system can be achieved by inhibition of IL17 production in CD11b+Ly6G+ neutrophils [86]. This evidence concerns the gene IL17A and neoplasm.